Outlook Therapeutics Stock Soars on Positive Results for Eye Treatment

Outlook Therapeutics Stock Soars on Positive Results for Eye Treatment

[ad_1]

Outlook Therapeutics  (OTLK) – Get Report climbed Tuesday after the biopharmaceutical company reported positive results for its treatment of neovascular age-related macular degeneration, or wet AMD.



[ad_2]

Source link